PC

Peter Crane

__

Oxford, England

Work Experience

  • Co-Founder and CEO

    2023

    Every patient's cells have a longer story to tell

  • Venture Partner (Techbio)

    2022

    Investing in the frontier of computer science and biology/chemistry Pre-seed to Seed | Tickets up to 1M Euros Peter[at]lunar.vc

2022 - 2022

  • Vice President Strategy

    2022 - 2022

    Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-a led biotech spinout from Oxford University, we empower the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high-efficiency vectors and intelligent clinical trial design.

2021 - 2021

  • Principal

    2021 - 2021

    On Investment Team. Deals included: Phenomic.AI (seed), Living Optics (seed), Kernal Biologics (pre-seed), Cytoseek (seed), Biomage (pre-seed, aquired) and Molecule One (seed).

2017 - 2021

  • Corporate Strategy Manager

    2019 - 2021

    Focus on digital tooling in bioprocessing, gene therapy, protein engineering and lab automation.

  • Business Development

    2017 - 2019

2018 - 2021

  • Venture Partner

    2018 - 2021

2016 - 2017

  • New Ventures Associate: Life-Sciences Ventures

    2016 - 2017

    Worked for a leading pharma company with a focus on therapeutic deal sourcing and evaluation

2014 - 2017

  • Chief Global Business Development Officer | Founding Member

    2014 - 2017

2014 - 2015

  • CASE Placement (Discovery Biology)

    2014 - 2015

  • Chapter President

    2013 - 2014